文献速递口腔修复与种植

唑来膦酸涂层对种植体早期稳定性和边缘骨吸收的影响

Impact of a zoledronate coating on early post-surgical implant stability and marginal bone resorption in the maxilla-A split-mouth randomized clinical trial.
PubMed 文献 · Clin Oral Implants Res · 2018-12-30

一项随机双盲分口临床试验纳入16例患者,比较唑来膦酸涂层与未涂层钛种植体在早期愈合(2-8周)的ISQ值和边缘骨水平。涂层种植体ISQ无显著差异,但边缘骨丧失更少(0.04 mm vs 0.12 mm,差0.17 mm,p<0.006)。

要点

  • 唑来膦酸涂层未显著改变种植体早期ISQ值
  • 涂层种植体边缘骨丧失显著少于未涂层种植体
  • 盲法定性评分显示涂层组边缘骨缺损更少

核心结论

  • 唑来膦酸涂层与未涂层种植体在早期愈合期ISQ值无显著差异。
  • 涂层种植体边缘骨丧失显著少于未涂层种植体。

研究设计与样本

  • 随机双盲分口临床试验,16例患者每人植入一枚涂层和一枚未涂层种植体。
  • 种植体均为骨水平钛种植体,表面中等粗糙度,颈部微螺纹。

主要发现

  • ISQ值在8周内基本保持恒定,各时间点涂层与未涂层种植体间无显著差异。
  • 边缘骨丧失:对照种植体0.12(SD 0.10)mm,涂层种植体0.04(SD 0.08)mm,差异0.17 mm(SD 0.14,p<0.006)。
  • 盲法定性评分:15枚对照种植体中13枚、15枚涂层种植体中2枚显示小边缘骨缺损(p=0.003)。

关键数值与推荐

  • 主要结局为第4周和第6周经植入值校正的ISQ值差异。
  • 次要结局为植入至8周边缘骨水平丧失。

临床怎么用

  • 唑来膦酸涂层可能有助于减少早期边缘骨吸收,但需进一步研究确认临床意义。

局限性

  • 样本量较小(16例患者)。
  • 随访时间短(8周)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objective of this clinical study was to evaluate the effect of a bisphosphonate coating on a titanium implant on the implant stability quotient (ISQ) and the radiographic marginal bone levels at implants during early healing (2-8 weeks). MATERIALS AND METHODS: In a randomized double-blind trial with internal controls, 16 patients received a dental implant coated with zoledronate and one uncoated implant as a control. The coated and uncoated implants which were visually indistinguishable were bone level titanium implants with a moderately rough surface and a microthreaded neck. ISQ values were obtained at insertion and at 2, 4, 6, and 8 weeks. Radiographs were obtained at insertion and at 8 weeks. The primary outcome was the difference in ISQ values between the coated implants and the control implants at 4 and 6 weeks, corrected for insertion values. The secondary outcome was loss of marginal bone level from insertion to 8 weeks. RESULTS: Implant stability quotient values remained largely constant over the 8 weeks, and there was no significant difference between coated and uncoated implants at any time point. There was 0.12 (SD 0.10) mm marginal bone loss at the control implants and 0.04 (SD 0.08) mm at the coated implants. The difference was 0.17 mm; SD 0.14; p < 0.006). On blind qualitative scoring, 13 of the 15 control implants and two of 15 coated implants showed small marginal bone defects (p = 0.003). CONCLUSIONS: There were no statistically significant differences observed in ISQ values between the coated and uncoated implants during the early healing. There was less marginal bone loss at the coated implants.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Abtahi J, Henefalk G, Aspenberg P, et al. Impact of a zoledronate coating on early post-surgical implant stability and marginal bone resorption in the maxilla-A split-mouth randomized clinical trial. Clin Oral Implants Res. 2018. PMID: 30565741. doi:10.1111/clr.13391

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。